APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Powerful Analgesics

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Powerful Analgesics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174027700330 December 2025196 pages

Choose your research edition.

Industry ResearchPowerful Analgesics Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Powerful Analgesics Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Powerful Analgesics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Powerful Analgesics Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal Powerful Analgesics Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

The global Powerful Analgesics market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Powerful Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Powerful Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Powerful Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Powerful Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Powerful Analgesics include Sun Pharmaceutical Industries, Teva, Shandong Keyuan Pharmaceutical, Novartis, Mylan, Pfizer, Northeast Pharmaceutical Group, Watson Laboratories and Stada Arzneimittel, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Powerful Analgesics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Powerful Analgesics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Powerful Analgesics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Powerful Analgesics market size, projected growth trends, production technologies, key applications, and end-use industries.

Powerful Analgesics Segment by Company

Sun Pharmaceutical Industries

Teva

Shandong Keyuan Pharmaceutical

Novartis

Mylan

Pfizer

Northeast Pharmaceutical Group

Watson Laboratories

Stada Arzneimittel

Sanofi Winthrop Industrie

Purdue Pharma

Mundipharma

Mallinckrodt Pharmaceuticals

Macfarlan Smith

Lannett

KV Pharmaceutical

Johnson and Johnson

Fresenius

Endo Pharmaceuticals

Barr Pharmaceuticals

Apotex

Alcaliber

Akorn

Powerful Analgesics Segment by Type

Morphine

Oxymorphone

Hydromorphone

Others

Powerful Analgesics Segment by Application

Hospital

Clinic

Others

Powerful Analgesics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Powerful Analgesics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Powerful Analgesics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Powerful Analgesics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Powerful Analgesics market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Powerful Analgesics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Powerful Analgesics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Powerful Analgesics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Powerful Analgesics Industry Trends Table 2. Powerful Analgesics Industry Drivers Table 3. Powerful Analgesics Industry Opportunities and Challenges Table 4. Powerful Analgesics Industry Restraints Table 5. Global Powerful Analgesics Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Powerful Analgesics Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Powerful Analgesics Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Powerful Analgesics Sales Market Share by Manufacturers Table 9. Global Powerful Analgesics Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Powerful Analgesics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Powerful Analgesics Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Powerful Analgesics Manufacturers, Product Type & Application Table 13. Global Powerful Analgesics Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Powerful Analgesics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Morphine Table 17. Major Manufacturers of Oxymorphone Table 18. Major Manufacturers of Hydromorphone Table 19. Major Manufacturers of Others Table 20. Global Powerful Analgesics Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Powerful Analgesics Sales by Type (2021-2026) & (K Units) Table 22. Global Powerful Analgesics Sales by Type (2027-2032) & (K Units) Table 23. Global Powerful Analgesics Sales Market Share by Type (2021-2026) Table 24. Global Powerful Analgesics Sales Market Share by Type (2027-2032) Table 25. Global Powerful Analgesics Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Powerful Analgesics Revenue by Type (2021-2026) & (K Units) Table 27. Global Powerful Analgesics Revenue by Type (2027-2032) & (K Units) Table 28. Global Powerful Analgesics Revenue Market Share by Type (2021-2026) Table 29. Global Powerful Analgesics Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Hospital Table 31. Major Manufacturers of Clinic Table 32. Major Manufacturers of Others Table 33. Global Powerful Analgesics Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Powerful Analgesics Sales by Application (2021-2026) & (K Units) Table 35. Global Powerful Analgesics Sales by Application (2027-2032) & (K Units) Table 36. Global Powerful Analgesics Sales Market Share by Application (2021-2026) Table 37. Global Powerful Analgesics Sales Market Share by Application (2027-2032) Table 38. Global Powerful Analgesics Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Powerful Analgesics Revenue by Application (2021-2026) & (K Units) Table 40. Global Powerful Analgesics Revenue by Application (2027-2032) & (K Units) Table 41. Global Powerful Analgesics Revenue Market Share by Application (2021-2026) Table 42. Global Powerful Analgesics Revenue Market Share by Application (2027-2032) Table 43. Global Powerful Analgesics Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Powerful Analgesics Sales by Region (2021-2026) & (K Units) Table 45. Global Powerful Analgesics Sales Market Share by Region (2021-2026) Table 46. Global Powerful Analgesics Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Powerful Analgesics Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Powerful Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Powerful Analgesics Sales by Country (2021-2026) & (K Units) Table 50. North America Powerful Analgesics Sales by Country (2027-2032) & (K Units) Table 51. Europe Powerful Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Powerful Analgesics Sales by Country (2021-2026) & (K Units) Table 53. Europe Powerful Analgesics Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Powerful Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Powerful Analgesics Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Powerful Analgesics Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Powerful Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Powerful Analgesics Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Powerful Analgesics Sales by Country (2027-2032) & (K Units) Table 60. Global Powerful Analgesics Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Powerful Analgesics Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Powerful Analgesics Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Powerful Analgesics Revenue Market Share by Region (2021-2026) Table 64. Global Powerful Analgesics Revenue Market Share by Region (2027-2032) Table 65. Sun Pharmaceutical Industries Company Information Table 66. Sun Pharmaceutical Industries Business Overview Table 67. Sun Pharmaceutical Industries Powerful Analgesics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Sun Pharmaceutical Industries Powerful Analgesics Product Portfolio Table 69. Sun Pharmaceutical Industries Recent Development Table 70. Teva Company Information Table 71. Teva Business Overview Table 72. Teva Powerful Analgesics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Teva Powerful Analgesics Product Portfolio Table 74. Teva Recent Development Table 75. Shandong Keyuan Pharmaceutical Company Information Table 76. Shandong Keyuan Pharmaceutical Business Overview Table 77. Shandong Keyuan Pharmaceutical Powerful Analgesics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Shandong Keyuan Pharmaceutical Powerful Analgesics Product Portfolio Table 79. Shandong Keyuan Pharmaceutical Recent Development Table 80. Novartis Company Information Table 81. Novartis Business Overview Table 82. Novartis Powerful Analgesics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Novartis Powerful Analgesics Product Portfolio Table 84. Novartis Recent Development Table 85. Mylan Company Information Table 86. Mylan Business Overview Table 87. Mylan Powerful Analgesics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Mylan Powerful Analgesics Product Portfolio Table 89. Mylan Recent Development Table 90. Pfizer Company Information Table 91. Pfizer Business Overview Table 92. Pfizer Powerful Analgesics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Pfizer Powerful Analgesics Product Portfolio Table 94. Pfizer Recent Development Table 95. Northeast Pharmaceutical Group Company Information Table 96. Northeast Pharmaceutical Group Business Overview Table 97. Northeast Pharmaceutical Group Powerful Analgesics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Northeast Pharmaceutical Group Powerful Analgesics Product Portfolio Table 99. Northeast Pharmaceutical Group Recent Development Table 100. Watson Laboratories Company Information Table 101. Watson Laboratories Business Overview Table 102. Watson Laboratories Powerful Analgesics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Watson Laboratories Powerful Analgesics Product Portfolio Table 104. Watson Laboratories Recent Development Table 105. Stada Arzneimittel Company Information Table 106. Stada Arzneimittel Business Overview Table 107. Stada Arzneimittel Powerful Analgesics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Stada Arzneimittel Powerful Analgesics Product Portfolio Table 109. Stada Arzneimittel Recent Development Table 110. Sanofi Winthrop Industrie Company Information Table 111. Sanofi Winthrop Industrie Business Overview Table 112. Sanofi Winthrop Industrie Powerful Analgesics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Sanofi Winthrop Industrie Powerful Analgesics Product Portfolio Table 114. Sanofi Winthrop Industrie Recent Development Table 115. Purdue Pharma Company Information Table 116. Purdue Pharma Business Overview Table 117. Purdue Pharma Powerful Analgesics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Purdue Pharma Powerful Analgesics Product Portfolio Table 119. Purdue Pharma Recent Development Table 120. Mundipharma Company Information Table 121. Mundipharma Business Overview Table 122. Mundipharma Powerful Analgesics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Mundipharma Powerful Analgesics Product Portfolio Table 124. Mundipharma Recent Development Table 125. Mallinckrodt Pharmaceuticals Company Information Table 126. Mallinckrodt Pharmaceuticals Business Overview Table 127. Mallinckrodt Pharmaceuticals Powerful Analgesics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Mallinckrodt Pharmaceuticals Powerful Analgesics Product Portfolio Table 129. Mallinckrodt Pharmaceuticals Recent Development Table 130. Macfarlan Smith Company Information Table 131. Macfarlan Smith Business Overview Table 132. Macfarlan Smith Powerful Analgesics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Macfarlan Smith Powerful Analgesics Product Portfolio Table 134. Macfarlan Smith Recent Development Table 135. Lannett Company Information Table 136. Lannett Business Overview Table 137. Lannett Powerful Analgesics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. Lannett Powerful Analgesics Product Portfolio Table 139. Lannett Recent Development Table 140. KV Pharmaceutical Company Information Table 141. KV Pharmaceutical Business Overview Table 142. KV Pharmaceutical Powerful Analgesics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 143. KV Pharmaceutical Powerful Analgesics Product Portfolio Table 144. KV Pharmaceutical Recent Development Table 145. Johnson and Johnson Company Information Table 146. Johnson and Johnson Business Overview Table 147. Johnson and Johnson Powerful Analgesics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 148. Johnson and Johnson Powerful Analgesics Product Portfolio Table 149. Johnson and Johnson Recent Development Table 150. Fresenius Company Information Table 151. Fresenius Business Overview Table 152. Fresenius Powerful Analgesics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 153. Fresenius Powerful Analgesics Product Portfolio Table 154. Fresenius Recent Development Table 155. Endo Pharmaceuticals Company Information Table 156. Endo Pharmaceuticals Business Overview Table 157. Endo Pharmaceuticals Powerful Analgesics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 158. Endo Pharmaceuticals Powerful Analgesics Product Portfolio Table 159. Endo Pharmaceuticals Recent Development Table 160. Barr Pharmaceuticals Company Information Table 161. Barr Pharmaceuticals Business Overview Table 162. Barr Pharmaceuticals Powerful Analgesics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 163. Barr Pharmaceuticals Powerful Analgesics Product Portfolio Table 164. Barr Pharmaceuticals Recent Development Table 165. Apotex Company Information Table 166. Apotex Business Overview Table 167. Apotex Powerful Analgesics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 168. Apotex Powerful Analgesics Product Portfolio Table 169. Apotex Recent Development Table 170. Alcaliber Company Information Table 171. Alcaliber Business Overview Table 172. Alcaliber Powerful Analgesics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 173. Alcaliber Powerful Analgesics Product Portfolio Table 174. Alcaliber Recent Development Table 175. Akorn Company Information Table 176. Akorn Business Overview Table 177. Akorn Powerful Analgesics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 178. Akorn Powerful Analgesics Product Portfolio Table 179. Akorn Recent Development Table 180. Key Raw Materials Table 181. Raw Materials Key Suppliers Table 182. Powerful Analgesics Distributors List Table 183. Powerful Analgesics Customers List Table 184. Research Programs/Design for This Report Table 185. Authors List of This Report Table 186. Secondary Sources Table 187. Primary Sources List of Figures Figure 1. Powerful Analgesics Product Image Figure 2. Global Powerful Analgesics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Powerful Analgesics Market Size (2021-2032) & (US$ Million) Figure 4. Global Powerful Analgesics Sales (2021-2032) & (K Units) Figure 5. Global Powerful Analgesics Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Powerful Analgesics Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Morphine Image Figure 9. Oxymorphone Image Figure 10. Hydromorphone Image Figure 11. Others Image Figure 12. Global Powerful Analgesics Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Powerful Analgesics Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Powerful Analgesics Sales Market Share by Type (2021-2032) Figure 15. Global Powerful Analgesics Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Powerful Analgesics Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Powerful Analgesics Revenue Market Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Clinic Image Figure 20. Others Image Figure 21. Global Powerful Analgesics Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Powerful Analgesics Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Powerful Analgesics Sales Market Share by Application (2021-2032) Figure 24. Global Powerful Analgesics Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Powerful Analgesics Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Powerful Analgesics Revenue Market Share by Application (2021-2032) Figure 27. North America Powerful Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Powerful Analgesics Sales Market Share by Country (2021-2032) Figure 29. U.S. Powerful Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Powerful Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Powerful Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Powerful Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Powerful Analgesics Sales Market Share by Country (2021-2032) Figure 34. Germany Powerful Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Powerful Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Powerful Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Powerful Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Powerful Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Powerful Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Powerful Analgesics Sales Market Share by Country (2021-2032) Figure 41. China Powerful Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Powerful Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Powerful Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Powerful Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Powerful Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Powerful Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Powerful Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Powerful Analgesics Sales Market Share by Country (2021-2032) Figure 49. Brazil Powerful Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Powerful Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Powerful Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Powerful Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Powerful Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Powerful Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Powerful Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Powerful Analgesics Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Powerful Analgesics Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Powerful Analgesics Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Powerful Analgesics Revenue (2021-2032) & (US$ Million) Figure 60. North America Powerful Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Powerful Analgesics Revenue (2021-2032) & (US$ Million) Figure 62. Europe Powerful Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Powerful Analgesics Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Powerful Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Powerful Analgesics Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Powerful Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Powerful Analgesics Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Powerful Analgesics Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Morphine
  • Oxymorphone
  • Hydromorphone
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Sun Pharmaceutical Industries
  • Teva
  • Shandong Keyuan Pharmaceutical
  • Novartis
  • Mylan
  • Pfizer
  • Northeast Pharmaceutical Group
  • Watson Laboratories
  • Stada Arzneimittel
  • Sanofi Winthrop Industrie
  • Purdue Pharma
  • Mundipharma
  • Mallinckrodt Pharmaceuticals
  • Macfarlan Smith
  • Lannett
  • KV Pharmaceutical
  • Johnson and Johnson
  • Fresenius
  • Endo Pharmaceuticals
  • Barr Pharmaceuticals
  • Apotex
  • Alcaliber
  • Akorn

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Powerful Analgesics Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Powerful Analgesics Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Powerful Analgesics Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Powerful Analgesics Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Powerful Analgesics Market Dynamics
  1. 2.1 Powerful Analgesics Industry Trends
  2. 2.2 Powerful Analgesics Industry Drivers
  3. 2.3 Powerful Analgesics Industry Opportunities and Challenges
  4. 2.4 Powerful Analgesics Industry Restraints
3 Powerful Analgesics Market by Manufacturers
  1. 3.1 Global Powerful Analgesics Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Powerful Analgesics Sales by Manufacturers (2021-2026)
  3. 3.3 Global Powerful Analgesics Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Powerful Analgesics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Powerful Analgesics Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Powerful Analgesics Manufacturers, Product Type & Application
  7. 3.7 Global Powerful Analgesics Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Powerful Analgesics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Powerful Analgesics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Powerful Analgesics Tier 1, Tier 2, and Tier 3
4 Powerful Analgesics Market by Type
  1. 4.1 Powerful Analgesics Type Introduction
  2. 4.1.1 Morphine
  3. 4.1.2 Oxymorphone
  4. 4.1.3 Hydromorphone
  5. 4.1.4 Others
  6. 4.2 Global Powerful Analgesics Sales by Type
  7. 4.2.1 Global Powerful Analgesics Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Powerful Analgesics Sales by Type (2021-2032)
  9. 4.2.3 Global Powerful Analgesics Sales Market Share by Type (2021-2032)
  10. 4.3 Global Powerful Analgesics Revenue by Type
  11. 4.3.1 Global Powerful Analgesics Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Powerful Analgesics Revenue by Type (2021-2032)
  13. 4.3.3 Global Powerful Analgesics Revenue Market Share by Type (2021-2032)
5 Powerful Analgesics Market by Application
  1. 5.1 Powerful Analgesics Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Powerful Analgesics Sales by Application
  6. 5.2.1 Global Powerful Analgesics Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Powerful Analgesics Sales by Application (2021-2032)
  8. 5.2.3 Global Powerful Analgesics Sales Market Share by Application (2021-2032)
  9. 5.3 Global Powerful Analgesics Revenue by Application
  10. 5.3.1 Global Powerful Analgesics Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Powerful Analgesics Revenue by Application (2021-2032)
  12. 5.3.3 Global Powerful Analgesics Revenue Market Share by Application (2021-2032)
6 Global Powerful Analgesics Sales by Region
  1. 6.1 Global Powerful Analgesics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Powerful Analgesics Sales by Region (2021-2032)
  3. 6.2.1 Global Powerful Analgesics Sales by Region (2021-2026)
  4. 6.2.2 Global Powerful Analgesics Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Powerful Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Powerful Analgesics Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Powerful Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Powerful Analgesics Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Powerful Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Powerful Analgesics Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Powerful Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Powerful Analgesics Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Powerful Analgesics Revenue by Region
  1. 7.1 Global Powerful Analgesics Revenue by Region
  2. 7.1.1 Global Powerful Analgesics Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Powerful Analgesics Revenue by Region (2021-2026)
  4. 7.1.3 Global Powerful Analgesics Revenue by Region (2027-2032)
  5. 7.1.4 Global Powerful Analgesics Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Powerful Analgesics Revenue (2021-2032)
  8. 7.2.2 North America Powerful Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Powerful Analgesics Revenue (2021-2032)
  11. 7.3.2 Europe Powerful Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Powerful Analgesics Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Powerful Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Powerful Analgesics Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Powerful Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sun Pharmaceutical Industries
  2. 8.1.1 Sun Pharmaceutical Industries Company Information
  3. 8.1.2 Sun Pharmaceutical Industries Business Overview
  4. 8.1.3 Sun Pharmaceutical Industries Powerful Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sun Pharmaceutical Industries Powerful Analgesics Product Portfolio
  6. 8.1.5 Sun Pharmaceutical Industries Recent Developments
  7. 8.2 Teva
  8. 8.2.1 Teva Company Information
  9. 8.2.2 Teva Business Overview
  10. 8.2.3 Teva Powerful Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Teva Powerful Analgesics Product Portfolio
  12. 8.2.5 Teva Recent Developments
  13. 8.3 Shandong Keyuan Pharmaceutical
  14. 8.3.1 Shandong Keyuan Pharmaceutical Company Information
  15. 8.3.2 Shandong Keyuan Pharmaceutical Business Overview
  16. 8.3.3 Shandong Keyuan Pharmaceutical Powerful Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Shandong Keyuan Pharmaceutical Powerful Analgesics Product Portfolio
  18. 8.3.5 Shandong Keyuan Pharmaceutical Recent Developments
  19. 8.4 Novartis
  20. 8.4.1 Novartis Company Information
  21. 8.4.2 Novartis Business Overview
  22. 8.4.3 Novartis Powerful Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Novartis Powerful Analgesics Product Portfolio
  24. 8.4.5 Novartis Recent Developments
  25. 8.5 Mylan
  26. 8.5.1 Mylan Company Information
  27. 8.5.2 Mylan Business Overview
  28. 8.5.3 Mylan Powerful Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Mylan Powerful Analgesics Product Portfolio
  30. 8.5.5 Mylan Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer Powerful Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Powerful Analgesics Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 Northeast Pharmaceutical Group
  38. 8.7.1 Northeast Pharmaceutical Group Company Information
  39. 8.7.2 Northeast Pharmaceutical Group Business Overview
  40. 8.7.3 Northeast Pharmaceutical Group Powerful Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Northeast Pharmaceutical Group Powerful Analgesics Product Portfolio
  42. 8.7.5 Northeast Pharmaceutical Group Recent Developments
  43. 8.8 Watson Laboratories
  44. 8.8.1 Watson Laboratories Company Information
  45. 8.8.2 Watson Laboratories Business Overview
  46. 8.8.3 Watson Laboratories Powerful Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Watson Laboratories Powerful Analgesics Product Portfolio
  48. 8.8.5 Watson Laboratories Recent Developments
  49. 8.9 Stada Arzneimittel
  50. 8.9.1 Stada Arzneimittel Company Information
  51. 8.9.2 Stada Arzneimittel Business Overview
  52. 8.9.3 Stada Arzneimittel Powerful Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Stada Arzneimittel Powerful Analgesics Product Portfolio
  54. 8.9.5 Stada Arzneimittel Recent Developments
  55. 8.10 Sanofi Winthrop Industrie
  56. 8.10.1 Sanofi Winthrop Industrie Company Information
  57. 8.10.2 Sanofi Winthrop Industrie Business Overview
  58. 8.10.3 Sanofi Winthrop Industrie Powerful Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Sanofi Winthrop Industrie Powerful Analgesics Product Portfolio
  60. 8.10.5 Sanofi Winthrop Industrie Recent Developments
  61. 8.11 Purdue Pharma
  62. 8.11.1 Purdue Pharma Company Information
  63. 8.11.2 Purdue Pharma Business Overview
  64. 8.11.3 Purdue Pharma Powerful Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Purdue Pharma Powerful Analgesics Product Portfolio
  66. 8.11.5 Purdue Pharma Recent Developments
  67. 8.12 Mundipharma
  68. 8.12.1 Mundipharma Company Information
  69. 8.12.2 Mundipharma Business Overview
  70. 8.12.3 Mundipharma Powerful Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Mundipharma Powerful Analgesics Product Portfolio
  72. 8.12.5 Mundipharma Recent Developments
  73. 8.13 Mallinckrodt Pharmaceuticals
  74. 8.13.1 Mallinckrodt Pharmaceuticals Company Information
  75. 8.13.2 Mallinckrodt Pharmaceuticals Business Overview
  76. 8.13.3 Mallinckrodt Pharmaceuticals Powerful Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Mallinckrodt Pharmaceuticals Powerful Analgesics Product Portfolio
  78. 8.13.5 Mallinckrodt Pharmaceuticals Recent Developments
  79. 8.14 Macfarlan Smith
  80. 8.14.1 Macfarlan Smith Company Information
  81. 8.14.2 Macfarlan Smith Business Overview
  82. 8.14.3 Macfarlan Smith Powerful Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Macfarlan Smith Powerful Analgesics Product Portfolio
  84. 8.14.5 Macfarlan Smith Recent Developments
  85. 8.15 Lannett
  86. 8.15.1 Lannett Company Information
  87. 8.15.2 Lannett Business Overview
  88. 8.15.3 Lannett Powerful Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Lannett Powerful Analgesics Product Portfolio
  90. 8.15.5 Lannett Recent Developments
  91. 8.16 KV Pharmaceutical
  92. 8.16.1 KV Pharmaceutical Company Information
  93. 8.16.2 KV Pharmaceutical Business Overview
  94. 8.16.3 KV Pharmaceutical Powerful Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 KV Pharmaceutical Powerful Analgesics Product Portfolio
  96. 8.16.5 KV Pharmaceutical Recent Developments
  97. 8.17 Johnson and Johnson
  98. 8.17.1 Johnson and Johnson Company Information
  99. 8.17.2 Johnson and Johnson Business Overview
  100. 8.17.3 Johnson and Johnson Powerful Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Johnson and Johnson Powerful Analgesics Product Portfolio
  102. 8.17.5 Johnson and Johnson Recent Developments
  103. 8.18 Fresenius
  104. 8.18.1 Fresenius Company Information
  105. 8.18.2 Fresenius Business Overview
  106. 8.18.3 Fresenius Powerful Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Fresenius Powerful Analgesics Product Portfolio
  108. 8.18.5 Fresenius Recent Developments
  109. 8.19 Endo Pharmaceuticals
  110. 8.19.1 Endo Pharmaceuticals Company Information
  111. 8.19.2 Endo Pharmaceuticals Business Overview
  112. 8.19.3 Endo Pharmaceuticals Powerful Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Endo Pharmaceuticals Powerful Analgesics Product Portfolio
  114. 8.19.5 Endo Pharmaceuticals Recent Developments
  115. 8.20 Barr Pharmaceuticals
  116. 8.20.1 Barr Pharmaceuticals Company Information
  117. 8.20.2 Barr Pharmaceuticals Business Overview
  118. 8.20.3 Barr Pharmaceuticals Powerful Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Barr Pharmaceuticals Powerful Analgesics Product Portfolio
  120. 8.20.5 Barr Pharmaceuticals Recent Developments
  121. 8.21 Apotex
  122. 8.21.1 Apotex Company Information
  123. 8.21.2 Apotex Business Overview
  124. 8.21.3 Apotex Powerful Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Apotex Powerful Analgesics Product Portfolio
  126. 8.21.5 Apotex Recent Developments
  127. 8.22 Alcaliber
  128. 8.22.1 Alcaliber Company Information
  129. 8.22.2 Alcaliber Business Overview
  130. 8.22.3 Alcaliber Powerful Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Alcaliber Powerful Analgesics Product Portfolio
  132. 8.22.5 Alcaliber Recent Developments
  133. 8.23 Akorn
  134. 8.23.1 Akorn Company Information
  135. 8.23.2 Akorn Business Overview
  136. 8.23.3 Akorn Powerful Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Akorn Powerful Analgesics Product Portfolio
  138. 8.23.5 Akorn Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Powerful Analgesics Value Chain Analysis
  2. 9.1.1 Powerful Analgesics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Powerful Analgesics Production Mode & Process
  6. 9.2 Powerful Analgesics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Powerful Analgesics Distributors
  9. 9.2.3 Powerful Analgesics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst